Lars‐Ove Farnebo
- Molecular Biology top 10%
- Nephrology top 0.5%
- Cellular and Molecular Neuroscience top 2%
- Oncology top 5%
- Genetics top 5%
- Co-authors
- Bertil HambergerCatharina LarssonKjell FuxéG. JönssonH. HällmanKerstin SandelinLars GrimeliusFilip Farnebo
- Topics
- Parathyroid Disorders and Treatments (13 papers)Pancreatic and Hepatic Oncology Research (10 papers)Neuroscience and Neuropharmacology Research (9 papers)
- Journals
- New England Journal of MedicineJournal of Biological ChemistryThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Lars‐Ove Farnebo
49 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Biology 1.1k
- Nephrology 1.0k
- Cellular and Molecular Neuroscience 883
- Oncology 735
- Genetics 568
Countries citing papers authored by Lars‐Ove Farnebo
This map shows the geographic impact of Lars‐Ove Farnebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars‐Ove Farnebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars‐Ove Farnebo more than expected).
Fields of papers citing papers by Lars‐Ove Farnebo
This network shows the impact of papers produced by Lars‐Ove Farnebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars‐Ove Farnebo. The network helps show where Lars‐Ove Farnebo may publish in the future.
Co-authorship network of co-authors of Lars‐Ove Farnebo
This figure shows the co-authorship network connecting the top 25 collaborators of Lars‐Ove Farnebo. A scholar is included among the top collaborators of Lars‐Ove Farnebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars‐Ove Farnebo. Lars‐Ove Farnebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 16 | |
| 3 | 11 | |
| 4 | 12 | |
| 5 | 10 | |
| 6 | 32 | |
| 7 | 17 | |
| 8 | 4 | |
| 9 | 20 | |
| 10 | 33 | |
| 11 | 100 | |
| 12 | 132 | |
| 13 | 58 | |
| 14 | 93 | |
| 15 | 30 | |
| 16 | 4 | |
| 17 | 4 | |
| 18 | 385 | |
| 19 | 30 | |
| 20 | 47 |
About Lars‐Ove Farnebo
Lars‐Ove Farnebo is a scholar working on Nephrology, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 50 papers that have together received 3.2k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (13 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Neuroscience and Neuropharmacology Research (9 papers). The work is most often cited by research in Nephrology (1.0k citations), Cellular and Molecular Neuroscience (883 citations) and Oncology (735 citations). Lars‐Ove Farnebo has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Bertil Hamberger, Catharina Larsson, Kjell Fuxé, G. Jönsson, H. Hällman, Kerstin Sandelin, Lars Grimelius, Filip Farnebo, Torbjörn Malmfors and Anders Höög. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.